Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Cash from Operations (2016 - 2025)

iBio (IBIO) has disclosed Cash from Operations for 16 consecutive years, with 5241000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 34.38% to 5241000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 18606000.0, a 15.51% decrease, with the full-year FY2025 number at 15300000.0, up 17.54% from a year prior.
  • Cash from Operations was 5241000.0 for Q4 2025 at iBio, up from 5665000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3089000.0 in Q1 2025 to a low of 13959000.0 in Q3 2022.
  • A 5-year average of 6362550.0 and a median of 5290500.0 in 2023 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: tumbled 94.11% in 2021, then soared 61.75% in 2023.
  • iBio's Cash from Operations stood at 10686000.0 in 2021, then rose by 28.55% to 7635000.0 in 2022, then surged by 38.36% to 4706000.0 in 2023, then increased by 17.13% to 3900000.0 in 2024, then plummeted by 34.38% to 5241000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Cash from Operations are 5241000.0 (Q4 2025), 5665000.0 (Q3 2025), and 4611000.0 (Q2 2025).